The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125140122 12514012 2 F 20140606 20160803 20160630 20160912 PER US-JNJFOC-20160527939 JANSSEN 50.74 YR A F Y 0.00000 20160912 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125140122 12514012 1 SS XARELTO RIVAROXABAN 1 Oral Y N UNKNOWN 0 20 MG TABLET QD
125140122 12514012 2 SS XARELTO RIVAROXABAN 1 Oral Y N UNKNOWN 0 20 MG TABLET QD
125140122 12514012 3 SS XARELTO RIVAROXABAN 1 Oral Y N UNKNOWN 0 20 MG TABLET QD
125140122 12514012 4 SS XARELTO RIVAROXABAN 1 Oral Y N UNKNOWN 0 20 MG TABLET QD
125140122 12514012 5 SS XARELTO RIVAROXABAN 1 Oral Y N UNKNOWN 0 20 MG TABLET QD
125140122 12514012 6 SS XARELTO RIVAROXABAN 1 Oral Y N UNKNOWN 0 20 MG TABLET QD
125140122 12514012 7 SS XARELTO RIVAROXABAN 1 Oral Y N UNKNOWN 0 20 MG TABLET QD
125140122 12514012 8 SS XARELTO RIVAROXABAN 1 Oral Y N UNKNOWN 0 20 MG TABLET QD
125140122 12514012 9 PS XARELTO RIVAROXABAN 1 Oral Y N UNKNOWN 202439 20 MG TABLET QD
125140122 12514012 10 SS PLAVIX CLOPIDOGREL BISULFATE 1 Oral Y 0 75 MG TABLET QD
125140122 12514012 11 SS ASPIRIN. ASPIRIN 1 Oral Y 0 81 MG TABLET QD
125140122 12514012 12 SS ASPIRIN. ASPIRIN 1 Oral Y 0 TABLET
125140122 12514012 13 SS COUMADIN WARFARIN SODIUM 1 Unknown Y 0 UNSPECIFIED

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125140122 12514012 1 Atrial fibrillation
125140122 12514012 2 Atrial fibrillation
125140122 12514012 3 Atrial fibrillation
125140122 12514012 4 Cerebrovascular accident prophylaxis
125140122 12514012 5 Cerebrovascular accident prophylaxis
125140122 12514012 6 Cerebrovascular accident prophylaxis
125140122 12514012 7 Anticoagulant therapy
125140122 12514012 8 Anticoagulant therapy
125140122 12514012 9 Anticoagulant therapy
125140122 12514012 10 Arrhythmia
125140122 12514012 11 Product used for unknown indication
125140122 12514012 12 Product used for unknown indication
125140122 12514012 13 Atrial fibrillation

Outcome of event

Event ID CASEID OUTC COD
125140122 12514012 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125140122 12514012 Epistaxis
125140122 12514012 Faeces discoloured
125140122 12514012 Vaginal haemorrhage

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125140122 12514012 1 20140916 0
125140122 12514012 2 20141009 0
125140122 12514012 3 20140611 201406 0
125140122 12514012 4 20141009 0
125140122 12514012 5 20140916 0
125140122 12514012 6 20140611 201406 0
125140122 12514012 7 20140611 201406 0
125140122 12514012 8 20140916 0
125140122 12514012 9 20141009 0
125140122 12514012 10 20140613 0
125140122 12514012 11 20140613 0